Myostatin inhibition represents a significant area of muscle biology research, and two peptides — Follistatin 344 and ACE-031 — provide researchers with distinct tools for investigating this pathway.
Follistatin 344
Follistatin is an endogenous glycoprotein that binds and neutralizes members of the TGF-beta superfamily, including myostatin and activin. The 344-amino acid isoform is the most commonly used research variant. Studies have investigated follistatin’s effects on skeletal muscle mass, satellite cell proliferation, and muscle regeneration in preclinical models.
ACE-031
ACE-031 is a soluble form of the activin receptor type IIB (ActRIIB) that acts as a ligand trap for myostatin and related TGF-beta family members. In research, ACE-031 has been studied for its effects on muscle mass, bone density markers, and adipose tissue in various model systems.
Research Considerations
While both peptides target the myostatin pathway, their mechanisms differ. Follistatin directly binds myostatin, while ACE-031 sequesters multiple TGF-beta ligands through receptor competition. This distinction is important for researchers designing pathway-specific studies.
Availability
Both available in 1mg research concentrations from Vault Peptides. Analytical documentation is published where available.
Disclaimer: All products referenced in this article are intended for laboratory and research use only. They are not intended for human consumption. By purchasing from Vault Peptides, you acknowledge these products are for research purposes only and agree to comply with all applicable laws and regulations. Vault Peptides does not make any claims regarding efficacy or safety for non-research applications.
Vault Peptides. Research Use Only. Vault-Sealed.
Independent-lab certificates of analysis are published where available. USA-based. Orders ship on business days. Tracking is provided as soon as the label is generated.
Continue Your Research
RESEARCH DOCUMENTATION
Get new lot reports and research-documentation updates
Subscribe for analytical-report guides and updates to our research documentation.
Confirm your email to subscribe. Unsubscribe at any time. Privacy policy.
